Maryam Kouhsoltani1, Amirala Aghbali1, Behrooz Shokoohi2, Ronak Ahmadzadeh3. 1. Dental and Periodontal Research Center and Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Hematology Oncology Research Center and Department of Pathology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. 3. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
PURPOSE: Target therapy against molecular markers of EGFR family has been recently used in the treatment protocol of several diseases. However, the role of Her-2/neu in OSCC is a matter of controversy and more studies are required to clarify the role of Her-2/neu in OSCC. We aimed to investigate the role of Her-2/neu in the process of carcinogenesis in oral epithelium as ELP is a premalignant and OSCC is a malignant lesion, but RLP shows no evidence of premalignancy and malignancy.To our Knowledge, this is the first study comparing Her-2/neu expression in erosive lichen planus (ELP), reticular lichen planus (RLP), and oral squamous cell carcinoma (OSCC). METHODS: 60 samples, including 20 cases of RLP, 20 cases of ELP, and 20 cases of OSCC were evaluated immunohistochemically in this study. RESULTS: Our findings showed that there was not a significant increase in Her-2/neu expression from RLP to ELP and from ELP to OSCC. Therefore, Her-2/neu had no role in differentiating between RLP, ELP and OSCC and this protein does not contribute to the process of carcinogenesis in the oral epithelium. CONCLUSION: The lack of Her-2/neu overexpression indicates that molecular targeting of Her-2/neu protein is not recommended as an adjuvant therapy in OSCC and OLP.
PURPOSE: Target therapy against molecular markers of EGFR family has been recently used in the treatment protocol of several diseases. However, the role of Her-2/neu in OSCC is a matter of controversy and more studies are required to clarify the role of Her-2/neu in OSCC. We aimed to investigate the role of Her-2/neu in the process of carcinogenesis in oral epithelium as ELP is a premalignant and OSCC is a malignant lesion, but RLP shows no evidence of premalignancy and malignancy.To our Knowledge, this is the first study comparing Her-2/neu expression in erosive lichen planus (ELP), reticular lichen planus (RLP), and oral squamous cell carcinoma (OSCC). METHODS: 60 samples, including 20 cases of RLP, 20 cases of ELP, and 20 cases of OSCC were evaluated immunohistochemically in this study. RESULTS: Our findings showed that there was not a significant increase in Her-2/neu expression from RLP to ELP and from ELP to OSCC. Therefore, Her-2/neu had no role in differentiating between RLP, ELP and OSCC and this protein does not contribute to the process of carcinogenesis in the oral epithelium. CONCLUSION: The lack of Her-2/neu overexpression indicates that molecular targeting of Her-2/neu protein is not recommended as an adjuvant therapy in OSCC and OLP.
Authors: W Xia; Y K Lau; H Z Zhang; F Y Xiao; D A Johnston; A R Liu; L Li; R L Katz; M C Hung Journal: Clin Cancer Res Date: 1999-12 Impact factor: 12.531
Authors: A Lebeau; D Deimling; C Kaltz; A Sendelhofert; A Iff; B Luthardt; M Untch; U Löhrs Journal: J Clin Oncol Date: 2001-01-15 Impact factor: 44.544
Authors: D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich Journal: Science Date: 1989-05-12 Impact factor: 47.728
Authors: Atif J Khan; Bonnie L King; Benjamin D Smith; Grace L Smith; Michael P DiGiovanna; Darryl Carter; Bruce G Haffty Journal: Clin Cancer Res Date: 2002-02 Impact factor: 12.531
Authors: Henning Hanken; Robert Gaudin; Alexander Gröbe; Meike Fraederich; Wolfgang Eichhorn; Ralf Smeets; Ronald Simon; Guido Sauter; Katharina Grupp; Jacob R Izbicki; Susanne Sehner; Max Heiland; Marco Blessmann Journal: J Oral Pathol Med Date: 2014-03-20 Impact factor: 4.253
Authors: Yumna Adnan; Syed Muhammad Adnan Ali; Muhammad Sohail Awan; Romana Idress; Muhammad Ozair Awan; Hasnain Ahmed Farooqui; Hammad Afzal Kayani Journal: PLoS One Date: 2022-05-11 Impact factor: 3.752
Authors: Wanessa da Silva Silveira; Ezequiel Gregolin Bottezini; Maria Salete Linden; Isadora Rinaldi; Luiz Renato Paranhos; João Paulo de Carli; Micheline Trentin; Pâmela Letícia Dos Santos Journal: J Korean Assoc Oral Maxillofac Surg Date: 2017-12-27